Article Information
History
- December 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA
- 2Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA
- 3Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
- ↵*Corresponding author:
Jasmohan S Bajaj, MD, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, 1201 Broad Rock Boulevard, Richmond, Virginia, 23249, USA, Fax: 804 675 5816, Telephone: 804 675 5802, Email: jasmohan.bajaj{at}vcuhealth.org
Author contributions: JSB conceptualized the study and was involved in all aspects, SS and NP were involved in data analysis and drafting the manuscript, AK was involved in critical revisions. All authors approved the final version.
Posted December 08, 2024.
Rifaximin does not increase the rate of 30-day mortality in patients with cirrhosis and daptomycin in two National US-based cohorts
